Rempex Pharmaceuticals

About:

Rempex Pharmaceuticals engages in the discovery and development of antibacterial drugs for antibiotic resistance.

Website: http://www.rempexpharma.com

Top Investors: OrbiMed, Adams Street Partners, SV Health Investors, Vivo Capital, Frazier Healthcare Partners

Description:

Rempex Pharmaceuticals, Inc. is a San Diego-based pharmaceutical company focused on the discovery and development of new antibacterial drugs to meet the growing clinical need created by multi-drug resistant bacterial pathogens. The company’s internal development pipeline focuses on combining proprietary formulations, PK/PD strategies and novel potentiating agents with proven antibiotics to overcome or directly inhibit the molecular mechanisms in bacteria responsible for antibiotic resistance.

Total Funding Amount:

$67.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)rempexpharma.com

Founders:

Daniel D. Burgess, Jeffery Loutit, Michael Dudley

Number of Employees:

1001-5000

Last Funding Date:

2011-11-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai